Page 10 - Pharma

Takeda buys Ariad Pharmaceuticals for $ 5.2 billion

Acquisition significantly enhances Takeda's global oncology portfolio

Lupin launches pain killer drug morphine sulfate tablet in US

Tablet is a generic version of MS Contin ER, which had annual US sales of $ 282.9 mn

Integrate & innovate to deliver the best of healthcare services: Rohit MA

Budget should announce new initiatives to encourage use of mobile technology in healthcare sector

Recent advances in plastics technology for medical care: Dr Mosongo Moukwa

New materials & processing techniques will enable healthcare industry to create innovative products

Amgen and Immatics to collaborate for cancer drug research

Immatics to receive $ 30 mn upfront & potentially over $ 1 bn in milestone payments & royalties

Valeant sells three skincare brands to L'Oreal for $1.3 billion

The company has also sold off Dendreon Pharma to China's Sanpower Group for $ 819.9 mn

US-based PerkinElmer acquires Tulip Diagnostics

The deal will support PerkinElmer's growth in the Indian diagnostics market

Ajanta Pharma receives US FDA approval for antidepressant drug duloxetine

The approved product is a generic version of Eli Lilly & Co's Cymbalta capsule

Merck buys food safety testing specialist BioControl

The deal will enable Merck to offer complete workflow solutions for food pathogen testing

Granules India receives 11 observations from Portuguese drug regulator

Infarmed, Portugal, issued these observations for Granules India's Gagillapur facility

Aurobindo Pharma receives US FDA nod for epilepsy drug levetiracetam

The approved product has an estimated annual market size of $ 32 million in the US

Aurobindo acquires Portugal's Generis Farmaceutica for € 135 mn

The deal will help Aurobindo to establish itself as one of the leading generics players in Europe

US District Court rules in favour of Amgen in Repatha patents cases

The court has prohibited Sanofi & Regeneron from infringing two patents that Amgen holds for Repatha

Natco receives US FDA approval for cancer drug bendamustine

The approved product is generic version of Treanda, which has annual sales of about $ 133 mn in US

Hikal sells R&D property in Bengaluru

The land was lying vacant after Hikal consolidated its R&D operations in Pune in 2014

Nutraceutical ingredients maker OmniActive receives $ 35 mn from Everstone

It will use the money to execute acquisition opportunities as part of its inorganic growth strategy

Jubilant signs long-term supply contracts for radiopharmaceuticals in US

The US accounts for approximately 70% of the radiopharmaceuticals business' sales

FIPB approves Sweden-based Recipharm's Kemwell acquisition

In April 2016, Recipharm agreed to buy Kemwell's pharma contract development and manufacturing biz

Pros & cons of integrating AYUSH doctors into modern medicine

While the idea is good, there are many challenges in its implementation, says Dr Dharminder Nagar

Natco launches hepatitis C drug Velpanat in Nepal

Velpanat, a sofosbuvir-velpatasvir fixed dose combination, is generic version of Gilead's Epclusa